MedPath

Intraoperative Functional Ultrasound

Not Applicable
Completed
Conditions
Brain Lesion
Brain Tumor
Interventions
Device: Ultrasound device
Registration Number
NCT02656407
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Brief Summary

A wide spectrum of methods is used to image brain activation in vivo. It can be directly detected by neurons electrical activity imaging (cortical simulation mapping, calcium imaging, voltage sensitive dyes) or indirectly by imaging hemodynamic changes induced by the neurovascular coupling in the vessels surrounding the activated neurons (intrinsic optical imaging, photoacoustic imaging, positron emission tomography (PET), functional magnetic resonance imaging (fMRI)).

Ultrasound as the potential to complement these functional imaging techniques at low cost. Ultrasound imaging can do real-time in-depth imaging of brain. However, its use to imaging of major vessels has been limited until now due to its poor sensitivity. To overcome this limitation functional ultrasound (fUS) was developed in Institut Langevin since 2011. This technique enables high spatio-temporal resolution imaging of whole-brain microvasculature dynamics in response to brain activation without the need of contrast agent.

This fUS method relies on a new power Doppler imaging sequence sensitive enough to detect blood flow in most of cerebral vessels (arterioles, big venules and larger vessels). Repeating the acquisition of such ultrasensitive Doppler images over time enables to follow flow dynamics in such vessels modulated by local neuronal activity.

Applied to the rat brain, fUS was proved able to map brain activation at high spatiotemporal resolution and high signal to noise ratio. The aim of this study is now to apply fUS on human brain in intraoperative condition.

The main objective of this study is to find activation maps through intraoperative ultrasensitive Doppler compared to gold standard cortical simulation mapping and functional MRI.

Secondly the investigators want to test sensitivity of this new Doppler mode. fUS method will be used for different types of stimuli and intensity and the investigators will do some control acquisitions. Blood vessel density observed with a conventional Doppler will be compared to the one measured with the ultrasensitive Doppler to prove that this new Doppler mode enhance micro vessel visualization.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
23
Inclusion Criteria
  • Men and women, adults ( > 18 years old)
  • Participants who have to undergo brain surgery, awake or under general anesthesia, for tumor or lesion resection (all types of tumors and lesions, cortical or subcortical), with programmed intraoperative ultrasound and cortical simulation mapping.
  • Consent form signed by the patient after being informed (written and oral) of the research protocol.
  • Patient affiliate to the social welfare system
Exclusion Criteria
  • Minors ( < 18 years old)
  • Pregnant, parturient or breastfeeding women
  • Protected persons, under guardianship, or under any administrative or legal right and liberty revocation procedure
  • Patient without affiliation to the social welfare system

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Ultrasensitive DopplerUltrasound deviceIntraoperative ultrasensitive Doppler acquisitions by using an ultrasound device for functional area detection
Primary Outcome Measures
NameTimeMethod
Activation maps through intraoperative ultrasensitive Doppler compared to gold standards cortical simulation mapping and functional MRIDuring the surgery
Secondary Outcome Measures
NameTimeMethod
In depth micro vessel localizationDuring surgery

Blood vessel density observed with a conventional Doppler will be compared to the one measured with the ultrasensitive Doppler.

Sensitivity test of the new Doppler modeDuring surgery

fUS method will be tested for different types of stimuli and intensity and the investigators will do some control acquisitions.

Trial Locations

Locations (1)

Pitié Salpetriere Hospital

🇫🇷

Paris, Ile De France, France

© Copyright 2025. All Rights Reserved by MedPath